Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Capital Work in Progress

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹137 Cr₹64 Cr₹130 Cr₹223 Cr₹518 Cr

What is the latest Capital Work in Progress ratio of NATCO PHARMA ?

The latest Capital Work in Progress ratio of NATCO PHARMA is ₹137 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹137 Cr
Mar2023₹64 Cr
Mar2022₹130 Cr
Mar2021₹223 Cr
Mar2020₹518 Cr

How is Capital Work in Progress of NATCO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹137 Cr
113.53
Mar2023 ₹64 Cr
-50.35
Mar2022 ₹130 Cr
-42.03
Mar2021 ₹223 Cr
-56.87
Mar2020 ₹518 Cr -

Compare Capital Work in Progress of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,070.4 Cr -5.4% 2.3% -17.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 2.3% 5.6% 21.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr 1.5% 4.2% 51.2% Stock Analytics
CIPLA ₹123,222.0 Cr 0% 2.9% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr 0.6% 0.9% 23.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr 0.8% 1.8% -5.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.4%

2.3%

-17.5%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses